{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Drugs 2017, Part 3

Activity Steps

Purpose of Activity

To provide an overview of 11 drugs recently approved by the FDA.
Accreditation Statement:
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify indications for the 11 new drugs.
  2. List major adverse reactions associated with select new drugs.
  3. Discuss nursing considerations for the new drugs.
Price: $17.95

Credits:

  • ACPE 1.0 CEU



UAN 0431-0000-18-006-H04-P
Accreditation Statement:
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.


Professions: Pharmacist
Test Code: N1117APharm
Published: Nov 2017
Expires: 11/29/2021
Required Passing Score: 13/18 (72%)
Authors: Daniel A. Hussar, PhD
Categories: Pharmacology
Specialties: Pharmocotherapy